The present invention relates to novel imidazo[1,2-a]pyridine compounds of general formula (I):
as well as pharmaceutically acceptable salts thereof; wherein R
1
, R
2
, R
3
and R
4
are as defined in the claims. The compounds have specific affinity for GABA
A
receptor and are therefore useful in the treatment and prevention of diseases modulated by α
1
- and α
2
-GABA
A
receptors.
本发明涉及一种新型
咪唑[1,2-a]
吡啶化合物,其一般式为(I),以及其药学上可接受的盐;其中R1、R2、R3和R4如权利要求中所定义。该化合物具有特定的
GABAA受体亲和力,因此在治疗和预防α1-和α2-
GABAA受体调节的疾病方面具有用处。